Protalix BioTherapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Protalix BioTherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $3.24M.
  • Protalix BioTherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.61M, a 190% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $8.31M.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 45.9% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27.6M, a 323% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.31M +$23.2M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$14.9M +$12.7M +45.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$27.6M -$21.1M -323% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$6.52M +$11.8M +64.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$18.3M +$8.18M +30.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 -$26.5M +$57M +68.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 -$83.4M -$54.1M -184% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$29.4M -$87.4M -151% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $58M +$88M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 -$29.9M -$2.15M -7.75% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$27.8M -$16.2M -139% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 -$11.6M +$24.9M +68.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$36.5M -$7.53M -26% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 -$29M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.